- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Diagnostic Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Diagnostic Radiopharmaceuticals market size is estimated to be worth US$ 4512 million in 2021 and is forecast to a readjusted size of USD 7059.4 million by 2028 with a CAGR of 6.6% during review period. Oncology accounting for % of the Diagnostic Radiopharmaceuticals global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Technetium 99 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Diagnostic Radiopharmaceuticals include Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, and Bracco Imaging, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Diagnostic Radiopharmaceuticals market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Technetium 99
Fluorine 18
Other
Market segment by Application can be divided into
Oncology
Cardiology
Other
The key market players for global Diagnostic Radiopharmaceuticals market are listed below:
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diagnostic Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diagnostic Radiopharmaceuticals, with price, sales, revenue and global market share of Diagnostic Radiopharmaceuticals from 2019 to 2022.
Chapter 3, the Diagnostic Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostic Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Diagnostic Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diagnostic Radiopharmaceuticals.
Chapter 13, 14, and 15, to describe Diagnostic Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Diagnostic Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diagnostic Radiopharmaceuticals Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Diagnostic Radiopharmaceuticals Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size & Forecast
1.4.1 Global Diagnostic Radiopharmaceuticals Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Diagnostic Radiopharmaceuticals Sales in Volume (2017-2028)
1.4.3 Global Diagnostic Radiopharmaceuticals Price (2017-2028)
1.5 Global Diagnostic Radiopharmaceuticals Production Capacity Analysis
1.5.1 Global Diagnostic Radiopharmaceuticals Total Production Capacity (2017-2028)
1.5.2 Global Diagnostic Radiopharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diagnostic Radiopharmaceuticals Market Drivers
1.6.2 Diagnostic Radiopharmaceuticals Market Restraints
1.6.3 Diagnostic Radiopharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Cardinal Health
2.1.1 Cardinal Health Details
2.1.2 Cardinal Health Major Business
2.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Product and Services
2.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Product and Services
2.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Curium Pharma
2.3.1 Curium Pharma Details
2.3.2 Curium Pharma Major Business
2.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Product and Services
2.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Jubilant Pharma
2.4.1 Jubilant Pharma Details
2.4.2 Jubilant Pharma Major Business
2.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Product and Services
2.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bracco Imaging
2.5.1 Bracco Imaging Details
2.5.2 Bracco Imaging Major Business
2.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Product and Services
2.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Advanced Accelerator Applications
2.6.1 Advanced Accelerator Applications Details
2.6.2 Advanced Accelerator Applications Major Business
2.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product and Services
2.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 SIEMENS
2.7.1 SIEMENS Details
2.7.2 SIEMENS Major Business
2.7.3 SIEMENS Diagnostic Radiopharmaceuticals Product and Services
2.7.4 SIEMENS Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 China Isotope & Radiation
2.8.1 China Isotope & Radiation Details
2.8.2 China Isotope & Radiation Major Business
2.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product and Services
2.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Dongcheng Pharmaceutical Group
2.9.1 Dongcheng Pharmaceutical Group Details
2.9.2 Dongcheng Pharmaceutical Group Major Business
2.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product and Services
2.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lantheus
2.10.1 Lantheus Details
2.10.2 Lantheus Major Business
2.10.3 Lantheus Diagnostic Radiopharmaceuticals Product and Services
2.10.4 Lantheus Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Product and Services
2.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Diagnostic Radiopharmaceuticals Breakdown Data by Manufacturer
3.1 Global Diagnostic Radiopharmaceuticals Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Diagnostic Radiopharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Diagnostic Radiopharmaceuticals Manufacturer Market Share in 2021
3.4.2 Top 6 Diagnostic Radiopharmaceuticals Manufacturer Market Share in 2021
3.5 Global Diagnostic Radiopharmaceuticals Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Diagnostic Radiopharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diagnostic Radiopharmaceuticals Market Size by Region
4.1.1 Global Diagnostic Radiopharmaceuticals Sales in Volume by Region (2017-2028)
4.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Region (2017-2028)
4.2 North America Diagnostic Radiopharmaceuticals Revenue (2017-2028)
4.3 Europe Diagnostic Radiopharmaceuticals Revenue (2017-2028)
4.4 Asia-Pacific Diagnostic Radiopharmaceuticals Revenue (2017-2028)
4.5 South America Diagnostic Radiopharmaceuticals Revenue (2017-2028)
4.6 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Diagnostic Radiopharmaceuticals Sales in Volume by Type (2017-2028)
5.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2017-2028)
5.3 Global Diagnostic Radiopharmaceuticals Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Diagnostic Radiopharmaceuticals Sales in Volume by Application (2017-2028)
6.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2017-2028)
6.3 Global Diagnostic Radiopharmaceuticals Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
7.2 North America Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
7.3 North America Diagnostic Radiopharmaceuticals Market Size by Country
7.3.1 North America Diagnostic Radiopharmaceuticals Sales in Volume by Country (2017-2028)
7.3.2 North America Diagnostic Radiopharmaceuticals Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
8.2 Europe Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
8.3 Europe Diagnostic Radiopharmaceuticals Market Size by Country
8.3.1 Europe Diagnostic Radiopharmaceuticals Sales in Volume by Country (2017-2028)
8.3.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
9.2 Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
9.3 Asia-Pacific Diagnostic Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
10.2 South America Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
10.3 South America Diagnostic Radiopharmaceuticals Market Size by Country
10.3.1 South America Diagnostic Radiopharmaceuticals Sales in Volume by Country (2017-2028)
10.3.2 South America Diagnostic Radiopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
11.2 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
11.3 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Diagnostic Radiopharmaceuticals and Key Manufacturers
12.2 Manufacturing Costs Percentage of Diagnostic Radiopharmaceuticals
12.3 Diagnostic Radiopharmaceuticals Production Process
12.4 Diagnostic Radiopharmaceuticals Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Diagnostic Radiopharmaceuticals Typical Distributors
13.3 Diagnostic Radiopharmaceuticals Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Diagnostic Radiopharmaceuticals Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 4. Cardinal Health Major Business
Table 5. Cardinal Health Diagnostic Radiopharmaceuticals Product and Services
Table 6. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. GE Healthcare Major Business
Table 9. GE Healthcare Diagnostic Radiopharmaceuticals Product and Services
Table 10. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Curium Pharma Major Business
Table 13. Curium Pharma Diagnostic Radiopharmaceuticals Product and Services
Table 14. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Jubilant Pharma Major Business
Table 17. Jubilant Pharma Diagnostic Radiopharmaceuticals Product and Services
Table 18. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 20. Bracco Imaging Major Business
Table 21. Bracco Imaging Diagnostic Radiopharmaceuticals Product and Services
Table 22. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 24. Advanced Accelerator Applications Major Business
Table 25. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product and Services
Table 26. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 28. SIEMENS Major Business
Table 29. SIEMENS Diagnostic Radiopharmaceuticals Product and Services
Table 30. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 32. China Isotope & Radiation Major Business
Table 33. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product and Services
Table 34. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 36. Dongcheng Pharmaceutical Group Major Business
Table 37. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product and Services
Table 38. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lantheus Basic Information, Manufacturing Base and Competitors
Table 40. Lantheus Major Business
Table 41. Lantheus Diagnostic Radiopharmaceuticals Product and Services
Table 42. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Diagnostic Radiopharmaceuticals Product and Services
Table 46. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Diagnostic Radiopharmaceuticals Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Diagnostic Radiopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Diagnostic Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Diagnostic Radiopharmaceuticals Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Diagnostic Radiopharmaceuticals Production Site of Key Manufacturer
Table 52. Diagnostic Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 53. Diagnostic Radiopharmaceuticals Mergers & Acquisitions in the Past Five Years
Table 54. Global Diagnostic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 55. Global Diagnostic Radiopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 56. Global Diagnostic Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Diagnostic Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 59. Global Diagnostic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 60. Global Diagnostic Radiopharmaceuticals Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Diagnostic Radiopharmaceuticals Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Diagnostic Radiopharmaceuticals Price by Type (2017-2022) & (US$/Unit)
Table 63. Global Diagnostic Radiopharmaceuticals Price by Type (2023-2028) & (US$/Unit)
Table 64. Global Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 65. Global Diagnostic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 66. Global Diagnostic Radiopharmaceuticals Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Diagnostic Radiopharmaceuticals Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Diagnostic Radiopharmaceuticals Price by Application (2017-2022) & (US$/Unit)
Table 69. Global Diagnostic Radiopharmaceuticals Price by Application (2023-2028) & (US$/Unit)
Table 70. North America Diagnostic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 71. North America Diagnostic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 72. North America Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Diagnostic Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 75. North America Diagnostic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 76. North America Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 77. North America Diagnostic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 78. Europe Diagnostic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 79. Europe Diagnostic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 80. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 83. Europe Diagnostic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 84. Europe Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 85. Europe Diagnostic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 94. South America Diagnostic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 95. South America Diagnostic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 96. South America Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Diagnostic Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 99. South America Diagnostic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 100. South America Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 101. South America Diagnostic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 110. Diagnostic Radiopharmaceuticals Raw Material
Table 111. Key Manufacturers of Diagnostic Radiopharmaceuticals Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Diagnostic Radiopharmaceuticals Typical Distributors
Table 115. Diagnostic Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Picture
Figure 2. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type in 2021
Figure 3. Technetium 99
Figure 4. Fluorine 18
Figure 5. Other
Figure 6. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application in 2021
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Global Diagnostic Radiopharmaceuticals Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Diagnostic Radiopharmaceuticals Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Diagnostic Radiopharmaceuticals Sales (2017-2028) & (K Units)
Figure 13. Global Diagnostic Radiopharmaceuticals Price (2017-2028) & (US$/Unit)
Figure 14. Global Diagnostic Radiopharmaceuticals Production Capacity (2017-2028) & (K Units)
Figure 15. Global Diagnostic Radiopharmaceuticals Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Diagnostic Radiopharmaceuticals Market Drivers
Figure 17. Diagnostic Radiopharmaceuticals Market Restraints
Figure 18. Diagnostic Radiopharmaceuticals Market Trends
Figure 19. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturer in 2021
Figure 20. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturer in 2021
Figure 21. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Diagnostic Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Diagnostic Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 26. North America Diagnostic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 27. Europe Diagnostic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 29. South America Diagnostic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 31. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 32. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 33. Global Diagnostic Radiopharmaceuticals Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 35. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 36. Global Diagnostic Radiopharmaceuticals Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 38. North America Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 39. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 40. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 41. United States Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 45. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 46. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 47. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 48. Germany Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 57. China Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 64. South America Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 65. South America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 66. South America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals in 2021
Figure 78. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 79. Diagnostic Radiopharmaceuticals Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
